(MOG-A) Moog - Overview
Stock: Motion Controls, Actuation Systems, Flight Controls, Valves, Servos
EPS (Earnings per Share)
Revenue
Dividends
| Dividend Yield | 0.58% |
| Yield on Cost 5y | 1.53% |
| Yield CAGR 5y | 3.78% |
| Payout Consistency | 23.9% |
| Payout Ratio | 12.3% |
| Risk 5d forecast | |
|---|---|
| Volatility | 30.1% |
| Relative Tail Risk | -7.83% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 1.65 |
| Alpha | 51.81 |
| Character TTM | |
|---|---|
| Beta | 1.106 |
| Beta Downside | 1.060 |
| Drawdowns 3y | |
|---|---|
| Max DD | 33.21% |
| CAGR/Max DD | 1.50 |
Description: MOG-A Moog January 09, 2026
Moog Inc. (NYSE:MOG-A) designs, manufactures, and integrates precision motion- and fluid-control systems for OEMs and end users across aerospace, defense, and industrial markets, operating from the United States, Germany, and other global sites. The business is organized into four segments: Space & Defense, Military Aircraft, Commercial Aircraft, and Industrial, each supplying mission-critical actuation and control components for platforms ranging from missiles and satellites to commercial jets and heavy-machinery automation.
In FY 2023 Moog reported revenue of roughly $2.5 billion, with an operating margin near 12% and a backlog of $2.9 billion-indicating strong order flow. Year-over-year revenue grew about 8%, driven primarily by rising defense spending (U.S. defense budget up ~3% YoY) and the rebound in commercial aviation demand after the pandemic downturn. The Industrial segment benefited from heightened automation spending, while R&D intensity remained around 6% of revenue, supporting its high-mix product portfolio.
Note: The GICS sub-industry listed as “Agricultural & Farm Machinery” appears to be a classification error; Moog’s primary exposure is to aerospace & defense and industrial automation, not agriculture.
For a deeper, data-driven look at Moog’s valuation and peer benchmarks, the ValueRay platform provides a concise, research-ready snapshot.
Piotroski VR‑10 (Strict, 0-10) 7.0
| Net Income: 258.7m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.02 > 0.02 and ΔFCF/TA 5.75 > 1.0 |
| NWC/Revenue: 34.46% < 20% (prev 36.37%; Δ -1.90% < -1%) |
| CFO/TA 0.05 > 3% & CFO 245.3m > Net Income 258.7m |
| Net Debt (983.6m) to EBITDA (529.5m): 1.86 < 3 |
| Current Ratio: 2.33 > 1.5 & < 3 |
| Outstanding Shares: last quarter (32.0m) vs 12m ago -1.12% < -2% |
| Gross Margin: 27.28% > 18% (prev 0.27%; Δ 2701 % > 0.5%) |
| Asset Turnover: 92.76% > 50% (prev 87.35%; Δ 5.40% > 0%) |
| Interest Coverage Ratio: 5.87 > 6 (EBITDA TTM 529.5m / Interest Expense TTM 72.3m) |
Altman Z'' 5.75
| A: 0.31 (Total Current Assets 2.45b - Total Current Liabilities 1.05b) / Total Assets 4.55b |
| B: 0.64 (Retained Earnings 2.90b / Total Assets 4.55b) |
| C: 0.10 (EBIT TTM 424.0m / Avg Total Assets 4.37b) |
| D: 0.96 (Book Value of Equity 2.39b / Total Liabilities 2.49b) |
| Altman-Z'' Score: 5.75 = AAA |
Beneish M -2.96
| DSRI: 1.03 (Receivables 1.37b/1.21b, Revenue 4.06b/3.66b) |
| GMI: 0.99 (GM 27.28% / 26.91%) |
| AQI: 0.96 (AQ_t 0.22 / AQ_t-1 0.23) |
| SGI: 1.11 (Revenue 4.06b / 3.66b) |
| TATA: 0.00 (NI 258.7m - CFO 245.3m) / TA 4.55b) |
| Beneish M-Score: -2.96 (Cap -4..+1) = A |
What is the price of MOG-A shares?
Over the past week, the price has changed by +6.17%, over one month by +25.80%, over three months by +62.36% and over the past year by +68.66%.
Is MOG-A a buy, sell or hold?
- StrongBuy: 2
- Buy: 1
- Hold: 1
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the MOG-A price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 324.5 | 0.1% |
| Analysts Target Price | 324.5 | 0.1% |
| ValueRay Target Price | 486.1 | 49.9% |
MOG-A Fundamental Data Overview February 07, 2026
P/E Forward = 14.3266
P/S = 2.5515
P/B = 4.9456
Revenue TTM = 4.06b USD
EBIT TTM = 424.0m USD
EBITDA TTM = 529.5m USD
Long Term Debt = 1.05b USD (from longTermDebt, last quarter)
Short Term Debt = 4.69m USD (from shortTermDebt, last quarter)
Debt = 1.06b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 983.6m USD (from netDebt column, last quarter)
Enterprise Value = 11.33b USD (10.34b + Debt 1.06b - CCE 73.4m)
Interest Coverage Ratio = 5.87 (Ebit TTM 424.0m / Interest Expense TTM 72.3m)
EV/FCF = 104.9x (Enterprise Value 11.33b / FCF TTM 108.0m)
FCF Yield = 0.95% (FCF TTM 108.0m / Enterprise Value 11.33b)
FCF Margin = 2.66% (FCF TTM 108.0m / Revenue TTM 4.06b)
Net Margin = 6.38% (Net Income TTM 258.7m / Revenue TTM 4.06b)
Gross Margin = 27.28% ((Revenue TTM 4.06b - Cost of Revenue TTM 2.95b) / Revenue TTM)
Gross Margin QoQ = 26.74% (prev 27.66%)
Tobins Q-Ratio = 2.49 (Enterprise Value 11.33b / Total Assets 4.55b)
Interest Expense / Debt = 1.63% (Interest Expense 17.2m / Debt 1.06b)
Taxrate = 22.09% (22.4m / 101.2m)
NOPAT = 330.3m (EBIT 424.0m * (1 - 22.09%))
Current Ratio = 2.33 (Total Current Assets 2.45b / Total Current Liabilities 1.05b)
Debt / Equity = 0.51 (Debt 1.06b / totalStockholderEquity, last quarter 2.07b)
Debt / EBITDA = 1.86 (Net Debt 983.6m / EBITDA 529.5m)
Debt / FCF = 9.11 (Net Debt 983.6m / FCF TTM 108.0m)
Total Stockholder Equity = 1.96b (last 4 quarters mean from totalStockholderEquity)
RoA = 5.92% (Net Income 258.7m / Total Assets 4.55b)
RoE = 13.20% (Net Income TTM 258.7m / Total Stockholder Equity 1.96b)
RoCE = 14.08% (EBIT 424.0m / Capital Employed (Equity 1.96b + L.T.Debt 1.05b))
RoIC = 10.93% (NOPAT 330.3m / Invested Capital 3.02b)
WACC = 9.18% (E(10.34b)/V(11.40b) * Re(9.99%) + D(1.06b)/V(11.40b) * Rd(1.63%) * (1-Tc(0.22)))
Discount Rate = 9.99% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -33.33 | Cagr: -0.32%
[DCF Debug] Terminal Value 65.06% ; FCFF base≈108.0m ; Y1≈70.9m ; Y5≈32.3m
Fair Price DCF = N/A (negative equity: EV 525.0m - Net Debt 983.6m = -458.6m; debt exceeds intrinsic value)
EPS Correlation: 79.69 | EPS CAGR: 16.36% | SUE: 2.68 | # QB: 3
Revenue Correlation: 95.52 | Revenue CAGR: 9.96% | SUE: 4.0 | # QB: 6
EPS next Quarter (2026-03-31): EPS=2.36 | Chg30d=+0.123 | Revisions Net=+1 | Analysts=3
EPS current Year (2026-09-30): EPS=10.26 | Chg30d=+0.317 | Revisions Net=+0 | Growth EPS=+18.1% | Growth Revenue=+11.5%
EPS next Year (2027-09-30): EPS=11.49 | Chg30d=+0.527 | Revisions Net=+0 | Growth EPS=+12.0% | Growth Revenue=+6.0%